Health Care

Irish drugmaker Shire PLC Is offering to buy Baxalta Inc. for about $30 billion in stock in a move to solidify its position in rare disease treatments.

Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Tyson Foods Inc., down $4.39 to $39.96 The meat producer reported worse-than-expected fiscal third-quarter profit and cut its outlook, citing high cattle costs.

Relatives of an Ohio woman who died after being sent home from a hospital while having a heart attack have reached a $275,000 settlement with the facility.

Shares of MannKind stumbled Thursday after the French pharmaceutical giant Sanofi detailed low initial sales for a fast-acting, inhaled insulin developed by MannKind.

Anglo-Swedish drug firm AstraZeneca says second-quarter net income fell 12 percent to $697 million as competition from generic drug companies reduced sales.

Britain-based drugmaker GlaxoSmithKline has reported a drop in earnings in the first full quarter since its deal to swap some assets with Swiss rival Novartis.

Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Teva Pharmaceuticals Industries Ltd., up $10.15 to $72 The generic drugmaker is buying Allergan's generic pharmaceuticals business for $40.5 billion, expanding its industry position.

Pfizer Inc. (PFE) on Tuesday reported second-quarter net income of $2.63 billion.

Merck & Co. (MRK) on Tuesday reported second-quarter profit of $687 million.

French drugmaker Sanofi said Monday it will pay up to $300 million to buy a thyroid cancer drug from British competitor AstraZeneca.

Israel's Teva Pharmaceutical Industries Ltd. says it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion.

A doctor who serves as mayor of a northern New Jersey town pleaded not guilty Monday to charges that he took cash bribes and other kickbacks for referring patients to a medical imaging company.

Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Visa Inc., up $3.05 to $74.80 The payment processing company's third-quarter profit jumped 25 percent, helped by a double-digit rise in activity on its network.

The European Medicines Agency is recommending that the world's leading malaria vaccine be licensed even though it is only about 30 percent effective and that protection fades over time.

AbbVie Inc. (ABBV) on Friday reported second-quarter profit of $1.37 billion.

Higher sales of Amgen's blockbuster rheumatoid arthritis drug Enbrel and some newer drugs boosted second-quarter profit 7 percent.

The Food and Drug Administration said Thursday that some doctors and pharmacies are getting confused by the similar names of an antidepressant and a blood-thinning medicine.